Analysis of BAG3 plasma concentrations in patients with acutely decompensated heart failure

Clinica Chimica Acta

Volumn 445, Issue , 2015, Pages 73-78

  Gandhi, Parul U ^a   Gaggin, Hanna K ^a   Belcher, Arianna M ^a   Harisiades, Jamie E ^a   Basile, Anna ^b   Falco, Antonia ^b   Rosati, Alessandra ^b   Piscione, Federico ^c   Januzzi, James L ^a   Turco, M Caterina ^b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF SALERNO   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

BAG3; BCL 2 athanogene 3; Heart failure; Prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; BCL 2 ASSOCIATED ATHANOGENE 3; BRAIN NATRIURETIC PEPTIDE; HEAT SHOCK PROTEIN; PROADRENOMEDULLIN; UNCLASSIFIED DRUG; ADRENOMEDULLIN; APOPTOSIS REGULATORY PROTEIN; BAG3 PROTEIN, HUMAN; BIOLOGICAL MARKER; CELL SURFACE RECEPTOR; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; IL1RL1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ACUTE HEART FAILURE; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KIDNEY FUNCTION; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURVIVOR; ACUTE DISEASE; BLOOD; GENE EXPRESSION; GENETICS; HEART FAILURE; HEART STROKE VOLUME; HEART VENTRICLE; KIDNEY FUNCTION TEST; METABOLISM; PATHOPHYSIOLOGY; SURVIVAL; VERY ELDERLY;

ACUTE DISEASE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADRENOMEDULLIN; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; ATRIAL NATRIURETIC FACTOR; BIOMARKERS; FEMALE; GENE EXPRESSION; HEART FAILURE; HEART VENTRICLES; HUMANS; KIDNEY FUNCTION TESTS; MALE; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, CELL SURFACE; STROKE VOLUME; SURVIVAL ANALYSIS;

EID: 84925949985     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.02.048     Document Type: Article

References (28)

1. Ouwerkerk W., Voors A.A., Zwinderman A.H. Factors influencing the predictive power of models for predicting mortality and/or heart failure hospitalization in patients with heart failure. JACC Heart Fail 2014, 2:429-436.
2. Ahmad T., Fiuzat M., Pencina M.J., et al. Charting a roadmap for heart failure biomarker studies. JACC Heart Fail 2014, 2:477-488.
3. Januzzi J.L., Felker G.M. Surfing the biomarker tsunami at JACC: heart failure. JACC Heart Fail 2013, 1:213-215.
4. Takayama S., Xie Z., Reed J.C. An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. J Biol Chem 1999, 274:781-786.
5. Homma S., Iwasaki M., Shelton G.D., Engvall E., Reed J.C., Takayama S. Bag3 deficiency results in fulminant myopathy and early lethality. Am J Pathol 2006, 169:761-773.
6. Rosati A., Graziano V., De Laurenzi V., Pascale M., Turco M.C. Bag3: a multifaceted protein that regulates major cell pathways. Cell Death Dis 2011, 2:e141.
7. Norton N., Li D., Rieder M.J., et al. Genome-wide studies of copy number variation and exome sequencing identify rare variants in Bag3 as a cause of dilated cardiomyopathy. Am J Hum Genet 2011, 88:273-282.
8. Hishiya A., Kitazawa T., Takayama S. Bag3 and Hsc70 interact with actin capping protein Capz to maintain myofibrillar integrity under mechanical stress. Circ Res 2010, 107:1220-1231.
9. De Marco M., Falco A., Basile A., et al. Detection of soluble Bag3 and anti-Bag3 antibodies in patients with chronic heart failure. Cell Death Dis 2013, 4:e495.
10. De Marco M., D'Auria R., Rosati A., et al. Bag3 protein in advanced-stage heart failure. JACC Heart Fail 2014, 2:673-675.
11. Deberardinis B., Gaggin H.K., Magrini L., et al. Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure: results and validation of the Biomonitoring and Cardiorenal Syndrome in Heart Failure (BIONICS-HF) study. Clin Chem Lab Med 2014, 9(11):e112313.
12. Evaluation of precision performance of quantitative measurement methods; approved guideline-second edition. NCCLS Document EP5-A2 [ISBN 1-56238-542-9]. NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA 2004.
13. Gaggin H.K., Dang P.V., Do L.D., et al. Reference interval evaluation of high-sensitivity troponin T and N-Terminal B-type natriuretic peptide in Vietnam and the US: the North South East West trial. Clin Chem 2014, 60:758-764.
14. Pascual-Figal D.A., Casas T., Ordonez-Llanos J., et al. Highly sensitive troponin T for risk stratification of acutely destabilized heart failure. Am Heart J 2012, 163:1002-1010.
15. Pascual-Figal D.A., Manzano-Fernandez S., Boronat M., et al. Soluble St2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure. Eur J Heart Fail 2011, 13:718-725.
16. Legrand M., De Berardinis B., Gaggin H.K., et al. Evidence of uncoupling between renal dysfunction and injury in cardiorenal syndrome: insights from the BIONICS study. PLoS One 2014, 9:e112313.
17. Levey A.S., Stevens L.A., Schmid C.H., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
18. Borlaug B.A., Redfield M.M. Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation 2011, 123:2006-2013. [discussion 14].
19. Franceschelli S., Rosati A., Lerose R., De Nicola S., Turco M.C., Pascale M. Bag3 gene expression is regulated by heat shock factor 1. J Cell Physiol 2008, 215:575-577.
20. Kinnunen P., Vuolteenaho O., Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology 1993, 132:1961-1970.
21. Iwanaga Y., Nishi I., Furuichi S., et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006, 47:742-748.
22. van Veldhuisen D.J., Linssen G.C., Jaarsma T., et al. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol 2013, 61:1498-1506.
23. Malhotra V. Unconventional protein secretion: an evolving mechanism. EMBO J 2013, 32:1660-1664.
24. Kang R., Chen R., Zhang Q., et al. Hmgb1 in health and disease. Mol Aspects Med 2014, 40:1-116.
25. van Kimmenade R.R., Januzzi J.L. Emerging biomarkers in heart failure. Clin Chem 2012, 58:127-138.
26. Bayes-Genis A., de Antonio M., Vila J., et al. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: St2 versus galectin-3. J Am Coll Cardiol 2014, 63:158-166.
27. Felker G.M., Fiuzat M., Shaw L.K., et al. Galectin-3 in ambulatory patients with heart failure: results from the HF-action study. Circ Heart Fail 2012, 5:72-78.
28. Falco A., Rosati A., Festa M., et al. Bag3 is a novel serum biomarker for pancreatic adenocarcinomas. Am J Gastroenterol 2013, 108:1178-1180.